Clinical trial
Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects…
NCT00086463 · Actelion, Industry · Completed
Key facts
| NCT number | NCT00086463 |
|---|---|
| Title | Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH) |
| Official title | A Safety and Pilot Efficacy Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With PAH |
| Lead sponsor | Actelion, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pulmonary Arterial Hypertension, Ayerza Syndrome, Pulmonary Hypertension |
| Intervention type | Drug |
| Interventions | Iloprost or placebo |
| Enrollment | 60 |
| Start date | Jun 1, 2004 |
| Primary completion | Jan 1, 2006 |
| Completion | Jan 1, 2006 |
| First posted | Jul 5, 2004 |
| Last update posted | Apr 1, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: